CFT-2718 , CAS No.C1448889

CAS: C1448889 Cat. No.: C1448889 Formule: C45H47ClN10O3 Poids moléculaire: 811.37
DISPONIBLE À COMMANDE
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
Allemagne (EU)
USA*
Prix
Qté
1mg
C1448889-1mg
Sur commande · 8–12 semaines
Enter a quantity for the sizes you want to add.

Vue d’ensemble

CFT-2718 is a new BRD4-targeting degrader ( PROTAC ) with enhanced catalytic activity and in vivo properties.

Spécifications

Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Noms et identifiants
Poids moléculaire
811.37

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Avis

Avis des clients

Application Protocols

Not applicable. No validated application protocols (e.g., WB, IHC, IF, FC) are associated with this small‑molecule library item. For use as a test article in assays, develop and validate protocols appropriate to your platform, including solvent controls and compound stability checks.

Biological Roles

No structural or mechanistic information is provided for CFT-2718; therefore, specific biological roles, pathways, or targets cannot be assigned. This item is supplied strictly for research use, and any biological characterization must be determined empirically by the end user.

Guidance

  • If the compound is to be tested in biochemical or cell-based systems, pre‑validate solubility, stability, and lack of assay interference (fluorescence overlap, redox activity, aggregation). Include orthogonal assays to confirm any apparent activity.
  • Maintain transparent documentation of vehicle controls and final solvent percentages to ensure data interpretability.
Buffer Applications

This product is a small‑molecule library item rather than a buffering reagent. No buffer system parameters (pKa, effective pH range) are provided or implied. If the compound must be used in buffered systems, select a buffer appropriate to your assay (e.g., phosphate, HEPES, Tris) based on assay requirements, not on properties of this compound.

Green Alternatives

Because the structure and solvent compatibility of CFT-2718 are not provided, green chemistry considerations focus on solvent and handling choices during solution preparation and analytics.

  • Prefer greener solvents when feasible
    • Replace DMF/NMP with Cyrene, propylene carbonate, or dimethyl isosorbide for dissolution trials when compatible with assay and analytics.
    • For chromatographic methods, optimize for MeOH/H2O gradients before MeCN to reduce supply risk; ensure equal performance first.
  • DMSO alternatives
    • If DMSO cytotoxicity or regulatory constraints apply, explore aqueous solubilization via cyclodextrins (e.g., HP‑β‑CD) or low levels of ethanol/isopropanol. Validate stability and assay performance.
  • Waste minimization
    • Prepare minimal‑volume high‑concentration stocks to reduce solvent use and refrigerated storage burden.
    • Consolidate screening plates to minimize dead volumes and expired solutions.
  • Energy and cold-chain efficiency
    • Store at −20°C as specified, but avoid unnecessary deep‑freeze storage below this unless justified. Batch aliquot to reduce freezer door‑open time and freeze–thaw cycles.

Tradeoffs (general)

  • Greener co‑solvents may alter solubility or assay readouts. Implement parallel controls and conduct recovery experiments to confirm equivalence prior to full adoption.
Pharmaceutical Uses

No excipient status, pharmacopeial monograph, or formulation role is provided for CFT-2718. It is offered for research use only. Any discussion of therapeutic applications would be inappropriate without detailed characterization and is outside the scope of this listing. For formulation development studies, treat as an experimental research chemical and establish compound‑specific stability and compatibility empirically.

Physical Properties

Item-specific physicochemical parameters are not provided in the product data for CFT-2718.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable for solids; for oils/liquids, not specified for this item.

General guidance (literature/practice)

  • For unknown solids in screening libraries, begin solubility assessment with DMSO (analytical grade) at 10–50 mM, then dilute into aqueous buffers containing co‑solvent (e.g., 0.1–1% DMSO) as needed.
  • Rapid property estimation can be performed via LC–MS (elution behavior vs gradient), nephelometry (turbidity upon dilution), and thermal methods (DSC for polymorph/melting behavior) — these are general practices, not item-specific specifications.
  • If hygroscopic or deliquescent behavior is suspected, handle under dry atmospheres and weigh quickly; confirm by TGA where possible.
  • Always defer to the product’s CoA/SDS for authoritative, item-specific property data when available.
Quality and Grades

Grade/purity are not specified in the product data for CFT-2718; consult the CoA/Spec Sheet for item-specific purity, analytical methods, and acceptance criteria.

What to expect for small-molecule library items (general guidance)

  • Typical documentation: LC–MS or HPLC purity (often reported as area % at a specified wavelength/gradient), exact mass confirmation (ESI–MS), optional NMR snapshots for selected lots.
  • Purity terminology: “>95% (HPLC)” indicates chromatographic area percent by the reported method; it is not a universal specification and should be interpreted with the stated conditions.
  • Water/peroxide/metal content, residual solvents, and UV cutoff: Not specified for this item; refer to CoA/Spec Sheet. Do not assume trace impurity limits unless explicitly stated.
  • Salt form/hydrate: If the CoA lists a salt (e.g., HCl, TFA) or solvate, molecular weight and handling may differ from the free base/acid. Verify before weighing and preparing solutions.

Implications for use

  • For quantitative studies (e.g., screening curves, analytical standards), verify purity by in‑house LC–MS/HPLC against your method to ensure matrix compatibility.
  • For stability‑sensitive chemotypes (e.g., aldehydes, anhydrides, nitroso, Michael acceptors), request stabilizer information or test stability under your storage/assay conditions.
  • Document lot number and retain chromatograms/spectra used in your lab for traceability.
Reaction and Applications

The product is listed under “small molecules and compound libraries,” and no structure or functional groups are provided. As such, specific synthetic or reaction applications cannot be assigned responsibly.

Practical research uses (general, non-item-specific)

  • Screening/reference material: Utilize as a test article in biochemical, biophysical, or cell-free assays after confirming identity and purity (LC–MS/HPLC). Prepare DMSO stocks and validate solubility at working concentrations.
  • Analytical spike/standard: If an authentic standard is needed, establish a calibration curve under your analytical method if purity and response are verified.
  • Mechanistic probes: If structural information becomes available (e.g., electrophile, chelator, scaffold), design orthogonal assays to confirm on‑target vs off‑target effects; preclude pan‑assay interference (PAINS) behavior experimentally.

Tips

  • Confirm stability over assay time by re‑analyzing aliquots post‑incubation (LC–MS). Track potential adsorption to plastics for hydrophobic compounds (use low‑bind plastics or glass).
  • Document exact solvent content in wells/tubes; maintain constant DMSO percentage across controls and treatments.

For any synthetic transformation or named reaction relevance, consult the CoA/Spec Sheet for functional group data; none is provided in this listing.

Reaction Conditions

No reaction conditions are item-specific because the compound’s functional groups are not disclosed. Consequently, guidance here would be speculative. If you intend to perform transformations, first obtain or determine the structure and assess:

  • Solvent and temperature windows via small‑scale scouting (TLC/LC–MS monitoring).
  • Sensitivity to moisture, oxygen, acid/base, light, or heat via stress testing.
  • Catalyst/ligand compatibility if cross‑coupling handles are present.

For use as a test article rather than as a reagent, focus on assay conditions: ensure vehicle uniformity (e.g., 0.1–1% DMSO in all wells), monitor for precipitation upon dilution, and verify concentration by back‑calculation using LC–UV or LC–MS.

Safety and Handling

Hazard classification for CFT-2718 is not provided in the product data.

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word, hazard statements, pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (good practice)

  • Handle in a chemical fume hood with standard PPE: lab coat, safety glasses, and appropriate gloves (e.g., nitrile). Avoid inhalation of dust/aerosols and skin contact.
  • Storage incompatibilities should be assessed once functional groups are known. As a conservative default, segregate from strong oxidizers, strong acids/bases, and reactive reducing agents until compatibility is confirmed.
  • Minimize freeze–thaw cycles for DMSO or aqueous stocks to reduce degradation and precipitation.
  • For powder handling, consider antistatic measures and closed transfers to control particulates.

First-aid overview (consult SDS for specifics)

  • Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; seek medical attention if irritation persists.
  • Inhalation: Move to fresh air; seek medical attention if symptoms occur.
  • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.

Waste disposal

  • Dispose according to institutional and local regulations for organic laboratory chemicals. Collect halogenated vs non‑halogenated solvent waste separately when applicable.

Always defer to the product’s SDS for authoritative hazard and response information.

Solvent Selection

No solvent preferences are item-specific in the provided data. The following is practical guidance for small molecules of unknown chemotype.

  • Stock solution strategy
    • Start with anhydrous DMSO to 10–50 mM. Sonicate or gently warm (≤40°C) to aid dissolution, avoiding prolonged heating.
    • For poor DMSO solubility, screen co‑solvents: DMF, NMP, ethanol, or isopropanol, then back‑dilute into assay media with ≤1% organic content as tolerated by the system.
  • Miscibility considerations (general)
    • DMSO is miscible with water and most polar organics; precipitation may occur upon aqueous dilution if compound solubility is low. Pre-dilute DMSO stocks into an intermediate mixture (e.g., DMSO:water 1:1) to mitigate crash‑out.
    • For lipophilic analytes, use surfactants (e.g., 0.01–0.05% Tween 80) only if compatible with the assay; validate controls.
  • Analytical compatibility
    • For LC–MS, prefer MeCN/H2O or MeOH/H2O with volatile buffers (0.1% formic acid or 5–10 mM ammonium salts) to maintain ionization efficiency.
  • Drying and water sensitivity
    • If the compound is moisture‑sensitive (unknown here), employ dry solvents and inert atmosphere. Confirm by monitoring for hydrolysis in stability studies.

Selection relative to alternatives

  • When DMSO is unsuitable (cell-based sensitivity), consider PEG‑400 micro‑stocks or cyclodextrin inclusion complexes; verify assay tolerance before use.
Storage and Reconstitution

Storage

  • Store at −20°C (per product data). Maintain in a dry, closed container protected from light if the structure suggests photolability; absent such information, dark storage is a prudent default.
  • Shipping: Provided in an ice chest with ice pads. Upon receipt, promptly transfer to −20°C.

Reconstitution (general guidance; not item-specific)

  • For dry solids or films: Bring container to room temperature in a desiccator before opening to prevent moisture condensation. Weigh quickly. Dissolve initially in anhydrous DMSO to 10–50 mM. Gentle warming (≤40°C) and brief sonication can assist dissolution.
  • For aqueous use: Dilute DMSO stock into buffer or media with thorough mixing. Aim for a constant final DMSO content (typically ≤0.1–1% v/v) across samples and controls. Inspect for precipitation; if observed, increase co‑solvent fraction slightly or reduce concentration.

Aliquoting and stability

  • Prepare single‑use aliquots to avoid repeated freeze–thaw. Store aliquots at −20°C in tightly sealed, chemically compatible vials (low-bind recommended for hydrophobic analytes).
  • Record lot number, preparation date, solvent, and concentration on each aliquot. Periodically verify integrity by LC–MS/HPLC.

Note: Grade/purity, stabilizers, and exact solubility are not specified for this item; refer to the CoA/Spec Sheet and SDS for definitive instructions.

Structure and Identity

This entry refers to a small‑molecule library item designated CFT-2718 (SKU: C1448889), supplied for research use.

  • Chemical name: Not specified for this item; refer to CoA/Spec Sheet.
  • CAS: C1448889 (catalog-assigned placeholder; not a validated CAS RN)
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural description

  • Structural class and functional groups: Not provided in the product data. Without a structural diagram or line notation (SMILES), no reliable inference about ring systems, heteroatoms, or stereochemistry can be made.

Identification guidance (general)

  • For definitive identity, consult the product’s Certificate of Analysis (CoA) and/or Spec Sheet for canonical identifiers (SMILES, InChI, InChIKey) and analytical data (e.g., 1H/13C NMR, HRMS, LC–MS purity, HPLC traces).
  • If you receive a screening plate or dry film, retain the supplier map and well index; these serve as the de facto identity linkage for library items.
  • When establishing internal references, assign your own sample ID tied to analytical confirmation (LC–MS retention time and exact mass).
Synthetic Utility

Without a disclosed structure or functional group information, it is not possible to outline specific synthetic roles (e.g., nucleophile/electrophile behavior, cross‑coupling handles) for CFT-2718. If the structure becomes available, reassess synthetic utility by identifying:

  • Key reactive motifs (halides, boronates, carboxylates, carbonyls, heterocycles, protected amines/alcohols) and their compatibility.
  • Retrosynthetic disconnections to related analogs for SAR exploration, if medicinal chemistry campaigns are envisioned.
  • Stability liabilities (acid/base/oxidative lability) that govern protection/deprotection and late‑stage diversification.

Until then, treat this material as an endpoint test article rather than a building block.

Target Specificity

Not applicable. This listing is a small‑molecule library item with no target, epitope, clone, or species reactivity information. No biological target specificity is provided in the product data.

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.